Gene Query: ADAMTSL4

Dataset Description Geneva Score
Rorc disruption in human FG pancreatic cancer cells 208.57
Genome wide expression change by RNF168 knocking down in NEC cells 74.69
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 58.77
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 57.36
FOXD3 is a novel tumor suppressor in lung cancer 57.14
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 55.67
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 53.79
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 52.49
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 52.23
4sUDRB-seq: measuring transcription elongation and initiation genomewide 51.54
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 47.72
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 46.2
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 46.18
RNA-seq of human fibroblasts after irradiation 44.53
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 42.26
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 41.95
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 41.95
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 40.26
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 38.74
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 37.93
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 37.9
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 36.9
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 36.38
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 36.38
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 35.25
AUF-1 affected genes in human skin cells 33.48
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 31.21
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 30.79
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 30.51
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 28.7
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 28.49
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  28.06
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 27.58
RNA-seq of shEZH2 cells 26.03
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 25.31
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 25.1
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 24.74
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 24.28
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 24.05
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 23.85
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 23.14
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 22.54
BAF controls genome accessibility 22.4
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 22.33
MOF acetyl transferase regulates transcription and respiration in mitochondria 22.13
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 21.97
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 21.97
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 21.71
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 21.49
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 21.29
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 20.86
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 20.72
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 20.72
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 20.49
circRNA-sequencing 20.37
Tyrosine Kinase Inhibitor Cardiotoxicity 20.32
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 20.32
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 20.09
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 20.09
Accurate annotation of human protein-coding small open reading frames 19.92
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 19.81
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 19.51
The pause-initiation limit restricts transcription activation in human cells 19.5
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 19.46
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 19.31
Survival of pancreatic cancer cells lacking KRAS function 19.26
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 19.0
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 18.93
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 18.67
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 18.47
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 18.45
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 18.45
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 18.34
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 18.27
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 18.07
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 18.07
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 18.01
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 17.85
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 17.73
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 17.73
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 17.72
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 17.67
RNA-sequencing of human tendon after injury 17.65
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 17.65
Regulation of Lipids is Central to Replicative Senescence 17.64
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 17.59
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 17.11
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 16.99
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 16.98
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 16.98
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 16.9
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 16.84
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 16.66
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 16.62
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 16.52
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 16.37
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 16.28
SRSF2 mutations impair hematopoiesis and alter exon recognition 16.28
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 16.25
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 16.19
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 16.14
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 16.13
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 16.01
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 15.99
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 15.91
Transcriptome analysis of virus infected tissues 15.85
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 15.79
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 15.77
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 15.77
Recovery and analysis of nascent RNA 15.57
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 15.57
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 15.55
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 15.46
Targeting MTHFD2 in Acute Myeloid Leukemia 15.35
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 15.31
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 15.19
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 15.13
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 15.11
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 15.07
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 15.02
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 14.99
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 14.78
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 14.76
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 14.76
LncRNA expression profiling of ischemic stroke patients 14.72
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 14.66
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 14.57
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 14.42
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 14.34
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 14.23
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 14.21
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 13.96
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 13.9
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 13.9
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 13.86
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 13.79
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 13.79
A549 cell transcriptome responses to infection with H7N9 influenza virus 13.71
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 13.69
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 13.45
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 13.43
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 13.42
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 13.42
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 13.42
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 13.4
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 13.37
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 13.31
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 13.27
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 13.22
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 13.21
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 13.09
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 13.01
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 12.94
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 12.94
Leucegene: AML sequencing (part 6) 12.88
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 12.82
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 12.78
Neurofibroma 12.75
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 12.75
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 12.74
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 12.59
MEIS1 regulates hematopoiesis in hPSCs 12.55
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 12.54
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 12.44
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 12.44
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 12.39
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 12.34
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 12.32
Effect of drugs on transcriptomic profiles 12.28
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 12.06
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 12.02
Effect of mitochondria deficiency on senescence-associated gene expression 11.86
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 11.84
IDH3a KO RNA-seq 11.83
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 11.81
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 11.73
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 11.72
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 11.61
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 11.59
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 11.59
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 11.43
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 11.42
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 11.41
Functional Haploid Human Oocytes Generated from Polar Body Genomes 11.41
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 11.29
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 11.27
Gene expression analysis of immortalized human liver progenitor-like cells in culture 11.23
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 11.15
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 11.15
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 11.12
Macrophage Ad5f35 M2 Challenge 11.11
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 11.08
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 10.94
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.89
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 10.65
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 10.58
Nonpregnant and term pregnant human myometrial tissues 10.58
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 10.55
mRNA differential expression analysis in a human ex vivo model of chronic wounds 10.51
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 10.51
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 10.42
circRNA profile in hypopharyngeal cancer 10.42
CHD1 regulates cell fate determination by activation of differentiation-induced genes 10.32
IL-33 activates tumor stroma to promote intestinal polyposis 10.28
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 10.07
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 10.07
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 10.05
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 9.87
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 9.75
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 9.75
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 9.74
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 9.73
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 9.7
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 9.57
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 9.55
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 9.55
RNA-seq of MCF10A cells and CAF 9.54
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 9.54
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 9.43
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 9.42
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 9.41
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 9.41
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 9.32
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 9.31
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 9.28
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 9.22
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 9.21
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 9.15
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 9.14
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 9.11
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 9.11
MRTF activates TEAD-YAP target gene expression 9.05
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.05
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 8.82
LIN28A modulates splicing and gene expression programs in breast cancer cells 8.82
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 8.8
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 8.8
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 8.72
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 8.7
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 8.7
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 8.67
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 8.64
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 8.63
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 8.63
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.62
Random mono-allelic expression in MECP2-mutated cells 8.61
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 8.61
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 8.58
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.55
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 8.54
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 8.54
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 8.48
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 8.47
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 8.4
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 8.38
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 8.32
Chromatin-informed inference of transcriptional programs in gynecologic cancers 8.32
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 8.29
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 8.29
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 8.23
Transcriptome of human white and brown adipose tissue biopsies 8.01
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 7.97
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 7.84
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 7.78
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 7.67
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 7.66
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 7.65
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 7.61
Lipid degradation promotes prostate cancer cell survival 7.53
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 7.52
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 7.5
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 7.39
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 7.39
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 7.32
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 7.3
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 7.25
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.24
The comparison of high-throughput single-cell RNA-seq methods 7.24
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 7.23
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 7.21
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 7.18
Differential Gene Expression between MCF10A and MCF7 cells 7.08
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.99
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 6.92
RNA Seq of Alagille liver biopsies 6.87
Alagille_Nodder 6.87
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 6.84
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 6.77
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 6.77
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 6.77
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.7
Transcriptomes of oxLDL exposed trained monocytes 6.56
oxLDL exposed trained monocytes 6.56
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 6.54
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 6.48
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.46
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 6.44
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 6.44
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 6.37
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.36
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  6.33
4sU-seq of HFF exposed to salt and heat stress 6.29
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 6.25
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 6.25
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 6.21
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 6.21
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 6.09
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 6.08
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 6.08
RNA sequencing of GlyH-101-treated MCF-7 cell line 6.07
The circadian transcriptional landscape in primary human mammary epithelial cells 6.03
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 6.01
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.93
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 5.85
Expression charcaterization of an internal protocol developed to differentiate RPE cells 5.82
RNA-seq analysis of AML cells in response to ASLAN003 5.76
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 5.7
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 5.64
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 5.64
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 5.64
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.63
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 5.56
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.54
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.54
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.54
Transcription elongation regulates genome 3D structure 5.47
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.47
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.47
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 5.4
RNA-sequencing 5.35
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 5.2
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 5.19
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 5.18
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 5.18
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 5.15
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.14
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.14
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 5.14
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.14
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 5.1
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.1
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.1
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 5.08
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 5.06
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 5.06
Human optic chiasm from healthy controls and multiple sclerosis patients 4.98
Multiple sclerosis and EAE 4.98
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 4.81
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.75
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.75
Transcriptome sequencing of K-562 cells 4.72
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.71
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.66
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.66
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 4.66
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.61
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 4.61
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 4.6
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 4.53
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 4.5
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.48
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 4.46
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 4.45
IRF1 regulates IFN dependent and independent gene expression 4.44
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 4.43
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 4.26
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 4.25
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 4.17
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 4.11
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 4.11
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.04
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.98
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.9
Genome-wide discovery of human splicing branchpoints [RNAse] 3.71
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.67
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.67
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 3.65
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 3.65
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.6
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.6
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 3.59
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 3.59
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.57
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 3.56
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.51
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.49
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 3.48
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 3.39
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.36
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 3.23
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.22
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.22
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 3.19
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.17
Dysregulated immune system networks in war veterans with PTSD 3.11
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 3.11
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.1
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.1
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.1
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.09
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 3.08
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 3.0
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.96
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 2.95
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 2.94
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 2.93
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 2.93
Genome-wide discovery of human splicing branchpoints 2.88
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 2.88
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.87
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.87
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.8
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.74
Gene expression profiling of KSHV-infected periodontal ligament cells 2.59
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 2.56
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 2.56
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.53
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.51
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.5
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.48
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.38
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.38
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.27
Reprogrammed myeloid cell transcriptomes in NSCLC 2.26
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.26
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 2.24
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 2.22
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.08
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 2.04
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.98
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.98
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.9
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.86
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 1.81
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.78
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 1.71
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 1.71
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.71
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.67
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.63
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.61
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 1.6
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.6
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 1.58
Epigenome regulation during epidermal lineage commitment 1.47
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.47
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 1.44
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.44
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 1.42
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.36
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.33
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.33
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.24
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.22
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.2
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 1.16
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 1.16
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.15
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.15
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.1
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.09
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.99
RNA expression analysis upon JMJD1C depletion 0.96
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.96
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.95
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.95
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 0.86
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.85
Loss of endometrial plasticity in recurrent pregnancy loss 0.85
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.81
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.8
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.79
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.78
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.67
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.67
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.52
RNA-seq in endometrial stromal tumors 0.47
BMS-470539 on human synovial fibroblasts 0.47
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.44
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.38
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.36
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.33
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.33
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.31
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.26
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.23
Differential gene expression in Jagged1 treated human dental pulp cells. 0.23
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.22
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.21
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.19
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.15
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.11
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.11
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.09
Specific molecular signatures underlie response to decitabine in CMML 0.09
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.09
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.06
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.05
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.03
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation